UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 154

Sortiert nach

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Annals of oncology, 2019-03, Vol.30 (3), p.418-423

2019

Volltextzugriff (PDF)

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

Annals of oncology, 2019-06, Vol.30 (6), p.921-926

2019

Volltextzugriff (PDF)

Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

Annals of oncology, 2018-10, Vol.29, p.viii58-viii59

2018

Volltextzugriff (PDF)

First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER+/HER2- early breast cancer (BC) patients

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi31

2017

Volltextzugriff (PDF)

A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC)

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi27

2017

Volltextzugriff (PDF)

Separate cavity margins excision as a complement to conservative breast cancer surgery

European journal of surgical oncology, 2010-07, Vol.36 (7), p.632-638

2010

Volltextzugriff (PDF)

8746 POSTER Could Hypertension Be a Potential Biomarker in Patients With Recurrent Glioblastoma Treated With Antiangiogenic Drugs? -a Retrospective Analysis

European journal of cancer (1990), 2011, Vol.47, p.S587-S587

2011

Volltextzugriff (PDF)

Well-differentiated liposarcoma (atypical lipomatous tumors)

Seminars in diagnostic pathology, 2001-11, Vol.18 (4), p.258-262

2001

Volltextzugriff (PDF)

Diffuse leptomeningeal glioneuronal tumours: clinico-pathological follow-up

Pathologica, 2012-12, Vol.104 (6), p.428

2012

Volltextzugriff (PDF)

Heterogeneity of ER, PgR, HER2 and Ki67 in multifocal/multicentric breast cancer with a single histotype and same grade: implications for pathologists and oncologists from a large multi-institutional series

European journal of cancer (1990), 2024-03, Vol.200, p.113619, Article 113619

2024

Volltextzugriff (PDF)

Choroid Plexus and Aquaporin-1: A Novel Explanation of Cerebrospinal Fluid Production

Pediatric neurosurgery, 2004-11, Vol.40 (6), p.277-283

2004

Volltextzugriff (PDF)

Abstract P4-08-04: PD-L1 expression and prognosis in triple negative breast cancer (TNBC): An analysis of 265 patients (pts) treated with standard therapy for stage I-III disease

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-08-04

2019

Volltextzugriff (PDF)

19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study

Annals of oncology, 2020-05, Vol.31, p.S23-S23

2020

Volltextzugriff (PDF)

Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia

Seminars in diagnostic pathology, 2001-11, Vol.18 (4), p.267-273

2001

Volltextzugriff (PDF)

Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody

Modern pathology, 2004-05, Vol.17 (5), p.547-552

2004

Volltextzugriff (PDF)

Evidence of Epstein-Barr virus infection in ulcerative colitis

Digestive and liver disease, 2001-10, Vol.33 (7), p.551-558

2001

Volltextzugriff (PDF)

ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model

Annals of oncology, 2017-09, Vol.28, p.v63-v63

2017

Volltextzugriff (PDF)

New Immunohistochemical Markers Predictive of Response to Neoadjuvant Chemotherapy Plus Trastuzumab in HER2-Positive Locally Advanced Breast Cancer: A Single Center Experience

Annals of oncology, 2012-09, Vol.23, p.ix124

2012

Volltextzugriff (PDF)

Abstract P1-12-06: Factors related to the prognosis of breast cancer patients after the development of brain metastases

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-12-06

2017

Volltextzugriff (PDF)

Abstract P2-05-20: Tumor infiltrating lymphocytes in recurrent HER2+ and triple negative breast cancer: Prognostic value according to tumor phenotype

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-05-20

2017

Volltextzugriff (PDF)

First prospective multicenter Italian study on the impact of the 21-gene recurrence score® (RS) in adjuvant clinical decisions for ER + /HER2- early breast cancer patients

Annals of oncology, 2016-10, Vol.27, p.vi53-vi53

2016

Volltextzugriff (PDF)

Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast

Modern pathology, 2005-10, Vol.18 (10), p.1277-1282

2005

Volltextzugriff (PDF)

Abstract P1-13-02: Withdrawn

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-13-02

2018

Volltextzugriff (PDF)

Analysis of HER1 and HER2 status in CNS metastases from patients (pts) with breast carcinoma (BC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.1041-1041

2008

Volltextzugriff (PDF)

Triple negative breast cancer: Adjuvant treatment and outcome of 62 patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e11636-e11636

2009

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER+/HER2- early breast cancer (BC) patients

A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC)

Separate cavity margins excision as a complement to conservative breast cancer surgery

8746 POSTER Could Hypertension Be a Potential Biomarker in Patients With Recurrent Glioblastoma Treated With Antiangiogenic Drugs? -a Retrospective Analysis

Well-differentiated liposarcoma (atypical lipomatous tumors)

Diffuse leptomeningeal glioneuronal tumours: clinico-pathological follow-up

Heterogeneity of ER, PgR, HER2 and Ki67 in multifocal/multicentric breast cancer with a single histotype and same grade: implications for pathologists and oncologists from a large multi-institutional series

Choroid Plexus and Aquaporin-1: A Novel Explanation of Cerebrospinal Fluid Production

Abstract P4-08-04: PD-L1 expression and prognosis in triple negative breast cancer (TNBC): An analysis of 265 patients (pts) treated with standard therapy for stage I-III disease

19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study

Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia

Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody

Evidence of Epstein-Barr virus infection in ulcerative colitis

ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model

New Immunohistochemical Markers Predictive of Response to Neoadjuvant Chemotherapy Plus Trastuzumab in HER2-Positive Locally Advanced Breast Cancer: A Single Center Experience

Abstract P1-12-06: Factors related to the prognosis of breast cancer patients after the development of brain metastases

Abstract P2-05-20: Tumor infiltrating lymphocytes in recurrent HER2+ and triple negative breast cancer: Prognostic value according to tumor phenotype

First prospective multicenter Italian study on the impact of the 21-gene recurrence score® (RS) in adjuvant clinical decisions for ER + /HER2- early breast cancer patients

Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast

Abstract P1-13-02: Withdrawn

Analysis of HER1 and HER2 status in CNS metastases from patients (pts) with breast carcinoma (BC)

Triple negative breast cancer: Adjuvant treatment and outcome of 62 patients

Aktive Filter

Suchergebnisse filtern